IBDEI1MK ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27561,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,27562,0)
 ;;=E11.29^^106^1364^20
 ;;^UTILITY(U,$J,358.3,27562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27562,1,3,0)
 ;;=3^Type 2 DM w/ Oth Diabetic Kidney Complications
 ;;^UTILITY(U,$J,358.3,27562,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,27562,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,27563,0)
 ;;=E11.21^^106^1364^19
 ;;^UTILITY(U,$J,358.3,27563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27563,1,3,0)
 ;;=3^Type 2 DM w/ Diabetic nephropathy
 ;;^UTILITY(U,$J,358.3,27563,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,27563,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,27564,0)
 ;;=E11.22^^106^1364^18
 ;;^UTILITY(U,$J,358.3,27564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27564,1,3,0)
 ;;=3^Type 2 DM w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,27564,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,27564,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,27565,0)
 ;;=E10.29^^106^1364^17
 ;;^UTILITY(U,$J,358.3,27565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27565,1,3,0)
 ;;=3^Type 1 DM w/ Oth Diabetic Kidney Complications
 ;;^UTILITY(U,$J,358.3,27565,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,27565,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,27566,0)
 ;;=E10.21^^106^1364^16
 ;;^UTILITY(U,$J,358.3,27566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27566,1,3,0)
 ;;=3^Type 1 DM w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,27566,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,27566,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,27567,0)
 ;;=E10.22^^106^1364^15
 ;;^UTILITY(U,$J,358.3,27567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27567,1,3,0)
 ;;=3^Type 1 DM w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,27567,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,27567,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,27568,0)
 ;;=D59.3^^106^1364^3
 ;;^UTILITY(U,$J,358.3,27568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27568,1,3,0)
 ;;=3^Hemolytic-uremic syndrome
 ;;^UTILITY(U,$J,358.3,27568,1,4,0)
 ;;=4^D59.3
 ;;^UTILITY(U,$J,358.3,27568,2)
 ;;=^55823
 ;;^UTILITY(U,$J,358.3,27569,0)
 ;;=D69.0^^106^1364^4
 ;;^UTILITY(U,$J,358.3,27569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27569,1,3,0)
 ;;=3^Henoch-Schoeniein Purpura
 ;;^UTILITY(U,$J,358.3,27569,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,27569,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,27570,0)
 ;;=M30.0^^106^1364^11
 ;;^UTILITY(U,$J,358.3,27570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27570,1,3,0)
 ;;=3^Polyarteritis nodosa
 ;;^UTILITY(U,$J,358.3,27570,1,4,0)
 ;;=4^M30.0
 ;;^UTILITY(U,$J,358.3,27570,2)
 ;;=^5011738
 ;;^UTILITY(U,$J,358.3,27571,0)
 ;;=M31.0^^106^1364^5
 ;;^UTILITY(U,$J,358.3,27571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27571,1,3,0)
 ;;=3^Hypersensitivity angiitis
 ;;^UTILITY(U,$J,358.3,27571,1,4,0)
 ;;=4^M31.0
 ;;^UTILITY(U,$J,358.3,27571,2)
 ;;=^60279
 ;;^UTILITY(U,$J,358.3,27572,0)
 ;;=M31.31^^106^1364^21
 ;;^UTILITY(U,$J,358.3,27572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27572,1,3,0)
 ;;=3^Wegener's granulomatosis w/ renal involvement
 ;;^UTILITY(U,$J,358.3,27572,1,4,0)
 ;;=4^M31.31
 ;;^UTILITY(U,$J,358.3,27572,2)
 ;;=^5011745
 ;;^UTILITY(U,$J,358.3,27573,0)
 ;;=E85.8^^106^1364^1
 ;;^UTILITY(U,$J,358.3,27573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27573,1,3,0)
 ;;=3^Amyloidosis,Other
 ;;^UTILITY(U,$J,358.3,27573,1,4,0)
 ;;=4^E85.8
 ;;^UTILITY(U,$J,358.3,27573,2)
 ;;=^334034
 ;;^UTILITY(U,$J,358.3,27574,0)
 ;;=N28.89^^106^1364^6
 ;;^UTILITY(U,$J,358.3,27574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27574,1,3,0)
 ;;=3^Kidney & Ureter Disorders,Oth Specified
 ;;^UTILITY(U,$J,358.3,27574,1,4,0)
 ;;=4^N28.89
